Kirsten Bibbins-Domingo, PhD, MD, MAS, is the Lee Goldman, MD Endowed Chair in Medicine, Professor and Chair of the Department of Epidemiology and Biostatistics, and Professor of Medicine at the University of California, San Francisco. She is the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine, and she directs the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, a research center focused on discovery, implementation, policy, advocacy, and community engagement for communities at risk for poor health and inadequate healthcare. Dr. Bibbins-Domingo is a general internist and cardiovascular epidemiologist who uses observational epidemiology, pragmatic trials, and simulation modeling to examine the impact of clinical and public health approaches to cardiovascular disease prevention in the US, in US population subgroups, and in other countries globally. She is the Immediate Past Chair of the US Preventive Services Task Force where she served from 2010–2017 as a member, Vice-Chair, and Chair from 2016–2017. She is an inducted member of the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.
Ashish Jha, MD, MPH, is the Director of the Harvard Global Health Institute and the K.T. Li Professor of Global Health at Harvard Chan School of Public Health. He is a practicing General Internist at the VA Boston Healthcare System and also Professor of Medicine at Harvard Medical School. Dr. Jha received his MD from Harvard Medical School and then trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women’s Hospital at Harvard Medical School and received his MPH from Harvard Chan School of Public Health. His research endeavors focus on improving the quality and costs of healthcare systems with a specialized focus on the impact of policies. Dr. Jha has published over two hundred empirical papers and writes regularly about ways to improve healthcare systems, both in the US and globally. Dr. Jha was elected as a member of the National Academy of Medicine in 2013.
Panel Speakers and Moderators
Anirban Basu, PhD, is a Professor of Health Economics and the Stergachis Family Endowed Director of The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington. He has additional appointments in the Department of Health Services, the Department of Economics and the National Bureau of Economic Research. Anirban’s work sits at the intersection of microeconomics, statistics, and health policy. His research focuses on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research. He specializes in understanding heterogeneity in clinical and economic outcomes, micro behavior with respect to heterogeneous information, and the value of individualized care. Anirban is as an associate editor for Observational Studies, and in the past of Health Economics and the Journal of Health Economics. He served on the Second Panel on Cost-effectiveness in Health and Medicine. He is a past recipient of the ISPOR Methodology Awards and the Bernie O’Brien New Investigator Award. He is an elected Fellow of the American Statistical Association.
Sanjay Basu, MD, PhD, is an Assistant Professor of Medicine at Stanford. He is a primary care physician and epidemiologist. He received his undergraduate education from the Massachusetts Institute of Technology (MIT), was a Rhodes Scholar at Oxford University, and received his MD and PhD at Yale University before completing his residency training in internal medicine at the University of California in San Francisco. Dr. Basu conducts research on health and social policies to reduce morbidity and mortality from cardiovascular disease and type II diabetes in both the United States and internationally, typically using methods from the fields of computer science, econometrics, and large-scale data analysis. Dr. Basu is currently Director of the Analytics and Modeling Core of Stanford’s SPHERE Center (Stanford Precision Health for Ethnic and Racial Equity) as well as serving as Co-Director for the Health Disparities section of Stanford’s Center for Population Health Sciences. He also serves in an advisory capacity for the United Nations, the World Health Organization, the Columbia University GRAPH Center, and Harvard Medical School’s Center for Primary Care. In 2013, he was named one of the “Top 100 Global Thinkers” by Foreign Policy Magazine, and in 2015 he was awarded the NIH Director’s New Innovator Award.
Colin Boyle, MPP, MBA, is the Deputy Director of UCSF Global Health Sciences, dedicated to improving health and reducing inequities worldwide. Colin joined UCSF in 2012, after 15 years with the Boston Consulting Group (BCG), where he was a partner and managing director leading many of the firm’s social impact projects, helping industry and non-profit innovators develop new products to combat disease and bring them to market for health impact. At UCSF, Mr. Boyle has focused on analyzing the case for investments in health, playing a supporting role in the Lancet Commission on Investing in Health and contributing to other investment cases for specific conditions. He also has supported or led efforts at UCSF related to malaria, TB, neglected infectious diseases, maternal health, health systems strengthening, and regulatory sciences, and . Mr. Boyle joined the professional faculty at the Haas School of Business at UC Berkeley in (2012), and teaches courses at the graduate level around the leadership and management of social enterprises and nonprofit organizations. He is currently on the board of trustees of the Oakland Museum of California.
William H. Dow, PhD, is Kaiser Permanente Professor of Health Economics at the University of California–Berkeley’s School of Public Health. He directs the UC-Berkeley Center on the Economics and Demography of Aging (CEDA), is a Research Associate at the National Bureau of Economic Research, and previously served as Senior Economist at the White House Council of Economic Advisers. He received his PhD in economics from Yale University. Dow’s research analyzes economic aspects of health insurance, health behaviors, and health and demographic outcomes across the globe. Honors include the Kenneth J. Arrow Award given by the International Health Economics Association.
R. Adams Dudley, MD, MBA, (@RAdamsDudleyMD) is a Professor of Medicine and Health Policy at UCSF and Director of UCSF’s Center for Healthcare Value. He has spent decades helping consumers, employers, providers, insurers, and government develop strategies to improve the quality of and lower the cost of health care. For example, he currently runs a project with Consumer Reports to share with the public information about the cost and quality of care for specific conditions (for example, knee surgery). With the advent of electronic medical records, his work on measuring outcomes and health care value has evolved into extensive use of informatics. In 2005, he received the Robert Wood Johnson Foundation Investigator Award in Health Policy and in 2013 he received UCSF's Distinction in Mentoring Award. He has been elected to the American Society for Clinical Investigation and the Association of American Physicians.
Rita Hamad, MD, PhD, is an Assistant Professor at UCSF in the Philip R. Lee Institute for Health Policy Studies and the Department of Family & Community Medicine. She is a social epidemiologist and physician whose research involves the use of interdisciplinary quasi-experimental methods and big data linkages to examine the social determinants of health. She investigates how social and economic policies influence health disparities over the life course, with an emphasis on child health and cardiovascular disease in particular. In her work, she exploits natural experiments, such as the Great Recession or variation in the earned income tax credit, employing techniques that support causal inference such as instrumental variables analysis or difference-in-differences. She is the recipient of a K08 grant from NHLBI to evaluate the effects of education policy on cardiovascular disease.
Jean-Manuel Izaret, PhD, is a Senior Partner and Managing Director in the San Francisco office of the Boston Consulting Group. JMI leads the Pricing practice for BCG globally, and is currently a Fellow of the BCG Henderson Institute, BCG’s internal think tank, where he is working on pricing model theory and its application across industries. JMI has more than 25 years of experience in pricing strategy and execution, first as a practitioner and then as a consultant. He has worked across most industries, including med tech and high-tech, biopharmaceuticals, financial services, industrial goods, and consumer goods and services. He has led complete transformations of pricing practices with many leading firms globally. JMI holds a PhD in Marketing and a MS in Engineering from Ecole Centrale Paris, and a MS in Economics from the Paris Political Science Institute.
James G. Kahn, MD, MPH, is professor in the Philip R. Lee Institute for Health Policy Studies, Global Health Sciences), and the Department of Epidemiology and Biostatistics at UCSF. He is the founder and director of the UCSF Global Health Economics Consortium (GHECon). Dr. Kahn is an expert in cost-effectiveness analysis and associated methods of decision analysis, systematic review, meta-analysis, and costing. Dr. Kahn is the PI for the Consortium for the Assessment of Prevention Economics (CAPE), a multi-institution collaboration working with CDC to examine prevention and treatment strategies. He is also the PI for the UCSF component of a NIDA-funded modeling consortium now in year 18 of 20. He was the PI for Global Health Decisions, which examined efficacy data for interventions for 8 global health conditions. He is co-founder and UCSF PI for the Global Health Cost Consortium, a Gates Foundation-funded project to increase the availability and quality of cost data for treatment and prevention programs for HIV, TB, and other diseases. Dr. Kahn has been funded by NIH, HRSA, CDC, UNAIDS, WHO, the Institute for Cost-Effectiveness Research (ICER), the Bill and Melinda Gates Foundation, the Robert Wood Johnson Foundation, the Kaiser Family Fund, Kaiser Permanente Health Plan, and several private companies. He teaches three economics courses at UCSF.
Dhruv Kazi, MD, MSc, MS, FAHA, is a general cardiologist, outcomes researcher, and health economist at UCSF. His work focuses on improving long-term clinical outcomes among patients with cardiovascular disease in resource-scarce settings in the United States and overseas. Projects include the evaluation of health policies, novel diagnostic approaches, medical devices, drug therapy, and genetic testing using simulation modeling and the application of advanced statistical techniques to large observational datasets. He has examined the economics of the healthcare workforce in the US and in India, China, and Sub-Saharan Africa. His research aims to optimize health care expenditures to maximize societal value, including innovative solutions to expand the health care pie (e.g., low-cost mobile technologies or synergies between communicable and non-communicable diseases). Dr Kazi trained in India (Seth G.S. Medical College, Mumbai), Kenya (Moi University, Eldoret), the UK (London School of Economics and Political Science), and the US (Baylor College of Medicine; UC San Diego; Stanford University). He is a World Heart Federation Emerging Leader, an Asia21 Young Leader, and a UCSF Hellman Family Foundation Fellow. He serves as on the American Heart Association’s International Committee, and is an associate editor for Global Heart. When not torturing data, he enjoys portrait photography, rock climbing, and scuba diving.
Margot Kushel, MD, is a Professor of Medicine in the Division of General Internal Medicine at Zuckerberg San Francisco General Hospital and Trauma Center and core faculty in UCSF's Center for Vulnerable Populations. Margot's research includes health and health care utilization patterns of homeless adults and other vulnerable populations and the development and evaluation of novel interventions to improve outcomes in individuals seeking care in the safety net. She is the PI of multiple NIA funded projects addressing homelessness in older adults. Passionate about training the next generation of researchers, she directs the UCSF Primary Care Research Fellowship. Margot maintains an active clinical practice at ZSFG in both primary care and inpatient medicine.
Carol Levin, PhD, both an agricultural and health economist, is an associate professor in the Department of Global Health at the University of Washington. Her research focuses on the costs and cost-effectiveness of introducing and scaling up public health interventions and new technologies related to reproductive, maternal and child health and nutrition interventions, including HIV/AIDS, TB and vaccine preventable diseases. Previously, she provided technical guidance and coordinated the economic analysis for the Disease Control Priorities 3rd Edition—a nine-volume series aimed at strengthening evidence based priority setting in health and nutrition. Currently, she is the director of the Global Health Cost Consortium to generate improved estimates of costs for HIV and TB for use in planning, budgeting and economic evaluation. She also conducts research on food security, health and nutrition, with a particular focus on the intersection between agriculture, food systems, and health and nutrition outcomes. She most recently implemented and evaluated an integrated agriculture and health project to maximize health and nutrition outcomes in Western Kenya. She is also co-Chair for the Agriculture, Health and Nutrition (AHN) Academy Working Group on Economic Evaluation of Agriculture, Food and Livelihood Strategies for Health and Nutrition.
John Lin, MD, is an internist and a VA Health Services Research and Development Fellow at the VA Palo Alto and Stanford University. He completed his Internal Medicine residency at UCSF in 2017. His previous work includes cardiovascular risk factor modeling for the Global Burden of Disease 2010 project, where he demonstrated the growing burden of hypertension, diabetes, overweight, and cholesterol in low and middle income countries. His current work focuses on using decision science modeling to evaluate interventions to address cardiovascular disease in low and middle income countries and to evaluate the value of novel and high-cost therapeutics in the United States.
Dave Matthews, PhD, is a Principal in the San Francisco office of the Boston Consulting Group. Dave specializes in the biopharmaceutical, medical device, and technology industries on pricing, strategy, and R&D topics, and has served public, private, and nonprofit clients in major geographies including the US, Europe, Asia, and Africa. Dave is currently an Ambassador to the BCG Henderson Institute, BCG's internal think tank, where he develops and tests novel pricing models for health care ecosystems, with a focus on infectious diseases like Hepatitis C. Prior to joining BCG, Dave was a Postdoctoral Fellow in Physics at UC San Diego, founded a telemedicine start-up and consulted in the biotechnology space, and taught neuroscience as an adjunct professor. Dave received a PhD in Computational Neurobiology from the Salk Institute and UC San Diego as a National Science Foundation Fellow, and holds a BA in Molecular Biology from Princeton University.
Douglas K. Owens, MD, MS, is the Henry J. Kaiser, Jr., Professor at Stanford University, where he is a professor of medicine, and, by courtesy, of health research and policy, and of management science and engineering. As director of the Center for Health Policy in the Freeman Spogli Institute for International Studies and director of the Center for Primary Care and Outcomes Research (PCOR) in the Department of Medicine, Dr. Owens leads an interdisciplinary group of Stanford researchers who assess health policy both domestically and internationally. He is a general internist and associate director of the Center for Innovation to Implementation at the Veterans Affairs Palo Alto Health Care System. His research focuses on technology assessment, cost-effectiveness analysis, evidence synthesis, and methods for clinical decision making, with much of his work centered on HIV and cardiovascular disease. Dr. Owens chaired the Clinical Guidelines Committee of the American College of Physicians. He also served on the United States Preventive Services Task Force (USPSTF), which creates national guidelines on prevention services. Recently, he has helped lead the development of guidelines on screening for HIV, hepatitis C, hepatitis B, lung cancer, colorectal cancer, breast cancer, and use of aspirin and statins to prevent cardiovascular disease. He also serves on a committee that is developing guidelines for the conduct of economic analyses for health care in the United States and abroad.
Joshua Salomon, PhD, is Professor of Medicine in the Center for Health Policy / Center for Primary Care and Outcomes Research at Stanford University. He directs the Prevention Policy Modeling Lab, a multi-institution research consortium that conducts health and economic modeling with CDC to inform prevention and treatment policies for infectious disease. His research focuses on priority-setting in public health, including measurement and valuation of population health; modeling and forecasting of major causes of mortality and morbidity; and evaluation of public health policies and interventions. Salomon earned his Ph.D. in health policy and decision sciences from Harvard University. Prior to joining the Stanford faculty, he held positions at the World Health Organization and Harvard T.H. Chan School of Public Health.
Urmimala Sarkar, MD, MPH, is Associate Professor of Medicine at UCSF in the Division of General Internal Medicine and a primary care physician at San Francisco General Hospital’s Richard H. Fine People's Clinic. Dr. Sarkar’s research focuses on (1) patient safety in outpatient settings, including adverse drug events, missed and delayed diagnosis, and failures of treatment monitoring, (2) health information technology and social media to improve the safety and quality of outpatient care, and (3) implementation of evidence-based innovations in real-world, safety-net care settings.
Hilary Seligman, MD, MAS, is an Associate Professor at the University of California San Francisco in the Departments of Medicine and of Epidemiology and Biostatistics, where she directs the Food Policy, Health, and Hunger Research Program at the Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital. She is Senior Medical Advisor and Lead Scientist for Feeding America as well as the Director of the CDC’s Nutrition and Obesity Policy Research and Evaluation Network (NOPREN). Dr. Seligman’s expertise centers on the health implications of food insecurity in the US. Her policy work focuses on federal nutrition programs (such as the Supplemental Nutrition Assistance Program), food affordability and access, and income-related drivers of food choice. In addition to research, she also directs EatSF, San Francisco’s fruit and vegetable voucher program. Dr. Seligman is Board Certified in Internal Medicine and a Fellow of the American College of Physicians.
Sheri Weiser, MD, MPH, MA, is an internist, and Associate Professor of Medicine at the Division of HIV, Infectious Disease and Global Medicine at UCSF. Her research focuses on the impact of structural barriers to HIV prevention, treatment, and care in underserved populations in resource poor and resource rich settings. A large focus of her research has been on the role of food insecurity as a barrier to sustained engagement in care, adherence and optimal health among both HIV-infected and uninfected individuals. She has led studies related to food insecurity and other structural barriers to care in Botswana, Swaziland, Kenya, Uganda and the United States. She also has expertise in devising and evaluating food security and livelihood interventions as a way to improve health outcomes, with a particular interest in environmentally sustainable interventions. Dr. Weiser completed her medical degree at Harvard Medical School and residency training in internal medicine at UCSF. Dr. Weiser also earned an MA in Medical Anthropology from Harvard University and an MPH in Epidemiology from UC Berkeley.